Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land?

Bibliography

• Smith DE. The process addictions and the new ASAM definition of addiction. J Psychoactive Drugs 2012;44:1-4
   PubMed Web of Science ®Google Scholar
• Blum K, Sheridan PJ, Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med 1995;89(7):396-400
   Web of Science ®Google Scholar
• Leggio L, Kenna GA, Fenton M, et al. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev 2009;19:115-12
   PubMed Web of Science ®Google Scholar
• Comings DE, Blum K. Reward Deficiency Syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000;325-41
   PubMed Web of Science ®Google Scholar
• Blum K, Noble EP, Sheridan PJ, et al. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990;263(15):2055-60
   PubMed Web of Science ®Google Scholar
• Blum K, Kozlowski GP. Ethanol and neuromodulator interactions: a cascade model of reward. Alcohol and Behavior 1990;131-49
   Google Scholar
• Konova AB, Moeller SJ, Goldstein RZ. Common and distinct neural targets of treatment: changing brain function in substance addiction. Neurosci Biobehav Rev 2013;37:2806-17
   PubMed Web of Science ®Google Scholar
• Blum K, Febo M, McLaughlin T, et al. Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. J Behav Addict 2014;3(3):149-56
   Google Scholar
• Green AL, Zimmet SV Strous RD, et al. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry 1999;6(6):287-96
   PubMed Web of Science ®Google Scholar
• Rovai L, Maremmani AG, Pacini M, et al. Negative dimension in psychiatry. Amotivational syndrome as a paradigm of negative symptoms in substance abuse. Riv Psiciatri 2013;48(1):1-9
   PubMed Web of Science ®Google Scholar
• Blum K, Oscar-Berman M, Badgaiyan RD, et al. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Med Hypotheses 2014;82(5):606-14
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35(1):217-38
   PubMed Web of Science ®Google Scholar
• Jasinska AJ, Stein EA, Kaiser J, et al. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 2014;1-16
   PubMed Web of Science ®Google Scholar
• Viswanath H, Velasquez KM, Savjani R, et al. Interhemispheric insular and inferior frontal connectivity are associated with substance abuse in a psychiatric population. Neuropharmacology 2015;92C:63-8
   Google Scholar
• Febo M, Ferris CF. Oxytocin and vasopressin modulation of the neural correlates of motivation and emotion: results from functional MRI studies in awake rats. Brain Res 2014;1580:8-21
   PubMed Web of Science ®Google Scholar
• Blum K, Gold MS. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis. Med Hypotheses 2011;76(4):576-84
   PubMed Web of Science ®Google Scholar
• Ducci F, Goldman D. The Genetic basis of addictive disorders. Psychiatr Clin North Am 2012;35(2):495-519
   PubMed Web of Science ®Google Scholar
• Moeller SJ, Parvaz MA, Shumay E, et al. Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence. J Neurosci 2013;33(24):10027-36
   PubMed Web of Science ®Google Scholar
• Gold MS, Blum K, Oscar-Berman M, et al. Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children? Postgrad Med 2014;126(1):153-77
   PubMed Web of Science ®Google Scholar
• Blum K, Chen TJ, Downs BW, et al. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing “deprivation-amplification relapse therapy” (DART). Postgrad Med 2009;121(6):176-96
   PubMed Web of Science ®Google Scholar
• Gardner EL. Addiction and brain reward and antireward pathways. Adv Psychosom Med 2011;30:22-60
   PubMed Web of Science ®Google Scholar
• Blum K, Oscar-Berman M, Stuller E, et al. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther 2012;3(5):139
   Google Scholar
• Lazary J, Juhasz G, Hunyady L, et al. Personalized medicine can pave the way for the safe use of CB1 receptor antagonists. Trends Pharmacol Sci 2011;32(5):270-80
   PubMed Web of Science ®Google Scholar
• Blum K, Liu Y. Wang W, et al. rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgrad Med 2014;16:1-10
   Google Scholar
• Ray R, Loughead J, Wang Z, et al. Neuroimaging, genetics and the treatment of nicotine addiction. Behav Brain Res 2008;193(2):159-69
   PubMed Web of Science ®Google Scholar
• Falcone M, Smith RM, Chenoweth MJ, et al. Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology 2013;38(12):2327-37
   PubMed Web of Science ®Google Scholar
• Nester EJ. Epigenetic mechanisms of drug addiction. Neuropharmacology 2014; 76:259-68.
   Google Scholar
• Feng J, Nestler EJ. Epigenetic mechanisms of drug addiction. Curr Opin Neurobiol 2013;23(4):521-8
   PubMed Web of Science ®Google Scholar
• Walker DM, Cates HM, Heller EA, et al. Regulation of chromatin states by drugs of abuse. Curr Opin Neurobiol 2015;30C:112-21
   Google Scholar
• Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011;12(11):623-37
   PubMed Web of Science ®Google Scholar
• Labrie V, Pai S, Petronis A. Epigenetics of major psychosis: progress, problems and perspectives. Trends Genet 2012;28(9):427-35
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Utrankar A, Reyes JA, et al. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics 2012;13(10):1149-60
   PubMed Web of Science ®Google Scholar
• Pizzimenti CL, Lattal KM. Epigenetics and memory: causes, consequences, and treatments for post-traumatic stress disorder and addiction. Genes Brain Behav 2015;14(1):73-84
   PubMed Web of Science ®Google Scholar
• Shulha HP, Crisci JL, Reshetov D, et al. Human-specific histone methylation signatures at transcription start sites in prefrontal neurons. PLoS Biol 2012;10(11):e1001427
   PubMed Web of Science ®Google Scholar
• Bowirrat A, Chen TJ, Oscar-Berman M, et al. Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? Mol Neurobiol 2012;45(2):298-313
   PubMed Web of Science ®Google Scholar
• McHugh MJ, Demers CH, Salmeron BJ, et al. Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry 2014;5:16
   PubMed Web of Science ®Google Scholar
• Moonat S, Sakharkar AJ, Zhang H, et al. Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry 2013;73(8):763-73
   PubMed Web of Science ®Google Scholar
• Muschler MA, Hillemacher T, Kraus C, et al. DNA methylation of the POMC gene promoter is associated with craving in alcohol dependence. J Neural Transm 2010;117(4):513-19
   PubMed Web of Science ®Google Scholar
• Wang Z, Yan P, Hui T, et al. Epigenetic upregulation of PSD-95 contributes to the rewarding behavior by morphine conditioning. Eur J Pharmacol 2014;732:123-9
   PubMed Web of Science ®Google Scholar
• Blum K, Chen TJ, Morse S, et al. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine Dagonist therapy: part 2. Postgrad Med 2010;122(6):214-26
   PubMed Web of Science ®Google Scholar
• Shcmidt HD, Sangrey GR, Darnell SB, et al. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 2012;120(2):202-9
   PubMed Web of Science ®Google Scholar
• Shenker NS, Ueland PM, Polidoro S, et al. DNA methylation as a long-term biomarker of exposure to tobacco smoke. Epidemiology 2013;24(5):712-16
   PubMed Web of Science ®Google Scholar
• Bowirrat A, Chen TJ, Blum K, et al. Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability. Curr Neuropharmacol 2010;8(4):335-58
   PubMed Web of Science ®Google Scholar
• Solinas M, Thiriet N, Chavuet C, et al. Prevention and treatment of drug addiction by environmental enrichment. Prog Neurobiol 2010;92(4):572-92
   PubMed Web of Science ®Google Scholar
• Clarke TK, Schumann G. Gene-environment interactions resulting in risk alcohol drinking behavior are mediated by CRF and CRF1. Pharmacol Biochem Behav 2009;93(3):230-6
   PubMed Web of Science ®Google Scholar
• Blum K, Briggs AH. Effects of delta9 tetrahydrocannabinol (delta9-THC) on amphetamine-aggregate toxicity in mice. Curr Ther Res Clin Exp 1977;21(2):241-4
   PubMed Web of Science ®Google Scholar
• van der Kam EL, Ellenbroek BA, Cools AR. Gene - environment interactions determine the individual variability in cocaine self-administration. Neuropharmacology 2005;5):685-95
   PubMed Web of Science ®Google Scholar
• Plazas-Mayorca MD, Vrana KE. Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? J Proteome Res 2011;10(1):58-65
   PubMed Web of Science ®Google Scholar
• Wockner LF, Noble EP, Lawford BR, et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry 2014;4:e339
   PubMed Web of Science ®Google Scholar
• Robison AJ, Vialou V, Sun HS, et al. Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects. Neuropsychopharmacology 2014;39(5):1178-86
   PubMed Web of Science ®Google Scholar
• Kolshus E, Dalton VS, Ryan KM, et al. When less is more--microRNAs and psychiatric disorders. Acta Psychiatr Scand 2014;129(4):241-56
   PubMed Web of Science ®Google Scholar
• Sartor GC, St Laurent G3rd, Wahlestedt C. The Emerging Role of Non-Coding RNAs in Drug Addiction. Front Genet 2012;3:106
   PubMedGoogle Scholar
• Bali P, Kenny PJ. MicroRNAs and drug addiction. Front Genet 2013;4:43
   PubMedGoogle Scholar
• Wood EJ, Lipovich L. MicroRNAs in opioid addiction: elucidating evolution. Front Genet 2012;3:241
   Google Scholar
• He Y, Wang ZJ. Let-7 microRNAs and Opioid Tolerance. Front Genet 2012;3:110
   PubMedGoogle Scholar
• Barbierato M, Zusso M, Skaper SD, et al. MicroRNAs: Emerging Role in the Endogenous μ Opioid System. CNS Neurol Disord Drug Targets 2015;14(2):239-50
   PubMed Web of Science ®Google Scholar
• Zheng H, Law PY, Loh HH. Non-Coding RNAs Regulating Morphine Function: With Emphasis on the In vivo and In vitro Functions of miR-190. Front Genet 2012;3:113
   Google Scholar
• Nunez YO, Mayfield RD. Understanding Alcoholism Through microRNA Signatures in Brains of Human Alcoholics. Front Genet 2012;3:43
   Google Scholar
• Most D, Workman E, Harris RA. Synaptic adaptations by alcohol and drugs of abuse: changes in microRNA expression and mRNA regulation. Front Mol Neurosci 2014;7:85
   PubMed Web of Science ®Google Scholar
• Oberlin BG, Dzemidzic M, Bragulat V, et al. Limbic responses to reward cues correlate with antisocial trait density in heavy drinkers. Neuroimage 2012;60(1):644-52
   PubMed Web of Science ®Google Scholar
• Blum K, Wood RC, Braverman ER, et al. The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes’ theorem. Funct Neurol 1995;1):37-44
   PubMed Web of Science ®Google Scholar
• Gelernter J, Kranzler HR, Sherva R, et al. Genome-Wide Association Study of Nicotine Dependence in American Populations: Identification of Novel Risk Loci in Both African-Americans and European-Americans. Biol Psychiatry 2014;S0006-3223(14);00696-9
   Google Scholar
• Gelernter J, Kranzler HR, Sherva R, et al. Genome-wide association study of alcohol dependence: significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry 2014;1):41-9
   PubMed Web of Science ®Google Scholar
• Zuo L, Zhang XY, Wang F, et al. Genome-wide significant association signals in IPO11-HTR1A region specific for alcohol and nicotine codependence. Alcohol Clin Exp Res 2013;37(5):730-9
   PubMed Web of Science ®Google Scholar
• Yan J, Aliev F, Webb BT, et al. Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence. Addict Biol 2014;19(4):708-21
   PubMed Web of Science ®Google Scholar
• Levey DF, Le-Niculescu H, Frank J, et al. Genetic risk prediction and neurobiological understanding of alcoholism. Transl Psychiatry 2014;4:e391
   Google Scholar
• Farris SP, Arasappan D, Hunicke-Smith S, et al. Transcriptome organization for chronic alcohol abuse in human brain. Mol Psychiatry 2014;10.1038/mp.2014.159
   PubMedGoogle Scholar
• Pearson-Fuhrhop KM, Dunn EC, Mortero S, et al. Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS ONE 2014;9(5):e93772
   Google Scholar
• Thome J, Hässler F, Zachariou V. Gene therapy for psychiatric disorders. World J Biol Psychiatry 2011;1:16-18
   Google Scholar
• Blum K, Oscar-Berman M, Demetrovics Z, et al. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol 2014;50(3):765-96
   PubMed Web of Science ®Google Scholar
• O’Gara C, Stapleton J, Sutherland G, et al. Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet Genomics 2007;17(1):61-7
   PubMed Web of Science ®Google Scholar
• Vadasz C, Saito M, Gyetvai BM, et al. Glutamate receptor metabotropic 7 is cis-regulated in the mouse brain and modulates alcohol drinking. Genomics 2007;90(6):690-702
   PubMed Web of Science ®Google Scholar
• Gass JT, Olive MF. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 2008;75(1):518-65
   Google Scholar
• Crews FT, Zou J, Qin L. Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun 2011(Suppl 1):S4-S12
   Google Scholar
• Björk K, Hansson AC, Sommer WH. Genetic variation and brain gene expression in rodent models of alcoholism implications for medication development. Int Rev Neurobiol 2010;91:129-71
   PubMed Web of Science ®Google Scholar
• Kiefer F, Witt SH, Frank J, et al. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. Pharmacogenomics J 2011;11(5):368-74
   PubMed Web of Science ®Google Scholar
• Nielsen DA, Ji F, Yuferov V, et al. Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. Psychiatr Genet 2010;20(5):207-14
   PubMed Web of Science ®Google Scholar
• English BA, Hahn MK, Gizer IR, et al. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J Neurodev Disord 2009;1(4):252-63
   PubMed Web of Science ®Google Scholar
• Mahajan SD, Aalinkeel R, Reynolds JL, et al. Therapeutic targeting of “DARPP-32”: a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction. Int Rev Neurobiol 2009;88:199-222
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN, Jaradat SA, Hulse GK, et al. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res Notes 2012;5:497
   PubMedGoogle Scholar
• Chen JC, Chen PC, Chiang YC. Molecular mechanisms of psychostimulant addiction. Chang Gung Med J 2009;32(2):148-54
   PubMedGoogle Scholar
• Doehring A, Hentig Nv, Graff J. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics 2009;19(6):407-14
   PubMed Web of Science ®Google Scholar
• Goenjian AK, Noble EP, Steinberg AM, et al. Association of COMT and TPH-2 genes with DSM-5 based PTSD symptoms. J Affect Disord 2014;1752C:472-8
   Google Scholar
• Carpenter CL, Wong AM, Li Z, et al. Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity. Obesity (silver spring) 2013;21(9):E467-73
   Google Scholar
• Conner BT, Hellemann GS, Ritchie TL, et al. Genetic, personality, and environmental predictors of drug use in adolescents. J Subst Abuse Treat 2010;387(2):178-90
   Google Scholar
• Stice E, Yokum S, Burger K, et al. Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. J Neurosci 2012;32(29):10093-100
   PubMed Web of Science ®Google Scholar
• Sellman D. The 10 most important things known about addiction. Addiction 2010;105(1):6-13
   PubMed Web of Science ®Google Scholar
• Gelfand Y, Kaplitt MG. Gene Therapy for psychiatric disorders. World Neurosurg 2013;80(3-4):S32.e11-18
   Google Scholar
• Kömürcü E, Bilgiç A, Hergüner S. Relationship between extremity fractures and attention-deficit/hyperactivity disorder symptomatology in adults. Int J Psychiatry Med 2014;47(1):55-63
   PubMed Web of Science ®Google Scholar
• Dreyer JL. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. Methods Mol Biol 2010;614:3-35
   PubMedGoogle Scholar
• Serguera C, Bemelmans AP. Gene therapy of the central nervous system: General considerations on viral vectors for gene transfer into the brain. Rev Neurol (Paris) 2014;170(12):727-38
   PubMed Web of Science ®Google Scholar
• Biggs TA, Myers RD. Adenosine A1 receptor antisense infused in striatum of rats: actions on alcohol-induced locomotor impairment, blood alcohol, and body temperature. Alcohol 1997;6):617-21
   PubMed Web of Science ®Google Scholar
• Myers RD, Robinson DE. Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats. Alcohol 1099;18(2-3):225-33
   Google Scholar
• McClintick JN, McBride WJ, Bell RL, et al. Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking. Pharmacol Biochem Behav 2015;129:87-96
   PubMed Web of Science ®Google Scholar
• Rodd ZA, Bertsch BA, Strother WN, et al. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach. Pharmacogenmocis J 2007;7(4):222-56
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN, Jaradat SA, Hulse GK, et al. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res Notes 2012;5:497
   PubMedGoogle Scholar
• Thanos PK, Volkow ND, Frejmuth P, et al. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 2001;78(5):1094-103
   PubMed Web of Science ®Google Scholar
• Thanos PK, Rivera SN, Weaver K, et al. Dopamine D2R DNA transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci 2005;77(2):130-9
   PubMed Web of Science ®Google Scholar
• Ocaranza P, Quintanilla ME, Tampier L, et al. Gene therapy reduces ethanol intake in an animal model of alcohol dependence. Alcohol Clin Exp Res 2008;32(1):52-7
   PubMed Web of Science ®Google Scholar
• Carlezon WAJr, Thome J, Olson VG, et al. Regulation of cocaine reward by CREB. Science 1998;282(5397):2272-5
   PubMed Web of Science ®Google Scholar
• Choi KH, Whisler K, Graham DL, et al. Antisense-induced reduction in nucleus accumbens cyclic AMP response element binding protein attenuates cocaine reinforcement. Neuroscience 2006;137(2):373-83
   PubMed Web of Science ®Google Scholar
• Bahi A, Boyer F, Gumy C, et al. In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration. Eur J Neursci 2004;20(12):3473-88
   PubMed Web of Science ®Google Scholar
• Thanos PK, Michaelides M, Umegaki H, et al. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 2008;62(7):481-6
   PubMed Web of Science ®Google Scholar
• Hearing MC, Schwendt M, McGinty JF. Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int J Neuropsychopharmacol 2011;14(6):784-95
   PubMed Web of Science ®Google Scholar
• Brimijoin S. Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users. CNS Neurol Disord Drug Targets 2011;10(8):880-91
   PubMed Web of Science ®Google Scholar
• Anker JJ, Brimijoin S, Gao Y, et al. Cocaine hydrolase encoded in viral vector blocks the reinstatement of cocaine seeking in rats for 6 months. Biol Psychiatry 2012;71(8):700-5
   PubMed Web of Science ®Google Scholar
• Brimijoin S, Gao Y. Cocaine hydrolase gene therapy for cocaine abuse. Future Med Chem 2012;4(2):151-62
   PubMed Web of Science ®Google Scholar
• Pons S, Fattore L, Cossu G, et al. Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 2008;28(47):12318-27
   PubMed Web of Science ®Google Scholar
• Oreiarena MJ, Herrera-Solis A, Pons S, et al. Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration. Neuropharmacology 2012;63(2):235-41
   PubMed Web of Science ®Google Scholar
• Höllt V, Przewłocki R, Herz A. beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. Life Sci 1978;23(10):1057-65
   PubMed Web of Science ®Google Scholar
• Blum K, Briggs AH, Elston SF, et al. Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. Science 1982;216(4553):1425-7
   PubMed Web of Science ®Google Scholar
• He Y, Wu FX, Miao XR, et al. Suppression of acute morphine withdrawal syndrome by adenovirus-mediated β-endorphin in rats. Brain Res 2011;1422:13-19
   PubMed Web of Science ®Google Scholar
• Jain KK. Gene Therapy for pain. Expert Opin Biol Ther 2008;8(12):1855-66
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu X, Dong L, et al. Development of viral vectors for gene therapy for chronic pain. Pain Res Treat 2011;968218
   Google Scholar
• Lopez-Valpuesta FJ1, Nyce JW, Myers RD. NPY-Y1 receptor antisense injected centrally in rats causes hyperthermia and feeding. Neuroreport 1996;7(15-17):2781-4
   PubMed Web of Science ®Google Scholar
• Young KS. Treatment outcomes using CBT-IA with Internet-addicted patients. J Behav Addict 2013;2(4):209-15
   Web of Science ®Google Scholar
• Shimamura M, Nakagami H, Taniyama Y, et al. Gene therapy for peripheral arterial disease. Expert Opin Biol Ther 2014;14(8):1175-84
   PubMed Web of Science ®Google Scholar
• Alba-Ferrara L, Fernandez F, Salas R, et al. Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence. Addict Disord Their Treat 2014;13(4):159-69
   PubMedGoogle Scholar
• Zhang H, Guo H, Zhang YC, et al. Effect of manual acupuncture stimulation of “Baihui” (GV 20) and “Dazhui” (GV 14) on contents of 5-HT, dopamine and ACh and expression of 5-HT mRNA, DA mRNA and AChE mRNA in the hippocampus in methamphetamine addiction rats. Zhen Ci Yan Jiu 2014;39(5):362-6
   PubMedGoogle Scholar
• Volkow ND, Frieden TR, Hyde PS, et al. Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med 2014;370(22):2063-6
   PubMed Web of Science ®Google Scholar
• Blum K, Chen AL, Chen TJ, et al. LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Adv Ther 2008;25(9):894-913
   PubMed Web of Science ®Google Scholar
• Smucny J, Wylie KP, Tregellas JR. Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery. Trends Pharmacol Sci 2014;35(8):397-403
   PubMed Web of Science ®Google Scholar
• Ho MK, Goldman D, Heinz A, et al. Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther 2010;88(6):779-91
   PubMed Web of Science ®Google Scholar
• Orson FM, Wang R, Brimijoin S, et al. The future potential for cocaine vaccines. Expert Opin Biol Ther 2014;14(9):1271-83
   PubMed Web of Science ®Google Scholar
• Hicks MJ, Rosenberg JB, De BP, et al. AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation. Sci Transl Med 2012;4(140):140ra87
   PubMed Web of Science ®Google Scholar
• Blum K, Chen TJH, Williams L, et al. A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: exploring nutrigenomics. Gene Ther Mol Biol 2008;12:371-82
   Google Scholar